Repare Therapeutics Inc (OQ:RPTX)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
See Regulatory Filings on SEC
Company Contact
Address: 7210 Frederick-Banting, Suite 100
Tel: N/A
IR: See website
Key People
Jerel Davis
Independent Chairman of the Board
Lloyd M. Segal
President, Chief Executive Officer, Director
Steve Forte
Chief Financial Officer, Executive Vice President
Michael Zinda
Executive Vice President, Chief Scientific Officer
Maria Koehler
Executive Vice President and Chief Medical Officer
Business Overview
Repare Therapeutics Inc is a Canada-based precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations. Its approach integrates discoveries from several fields of cell biology including deoxyribonucleic acid (DNA) repair and synthetic lethality. Its SNIPRx platform combines a clustered regularly interspaced short palindromic repeats (CRISPR)-enabled gene editing target discovery method with protein crystallography, computational biology and clinical informatics. The Company's pipeline products are RP-3500, Manchester and Pol0.
Financial Overview
For the three months ended 31 March 2020, Repare Therapeutics Inc revenues was not reported. Net loss increased from $4.8M to $12.6M. Higher net loss reflects rea increase from $3.7M to $8.5M (expense), Realized and unrealized (loss) gain on f decrease from $72K (income) to $1.7M (expense), General and administrative - Balancing v increase of 95% to $2M (expense).
Employees: 64 as of Mar 31, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $931.59M as of Mar 31, 2020
Annual revenue (TTM): $0.00M as of Mar 31, 2020
EBITDA (TTM): -$31.73M as of Mar 31, 2020
Net annual income (TTM): -$34.98M as of Mar 31, 2020
Free cash flow (TTM): -$32.25M as of Mar 31, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 34,057,559 as of Jun 19, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.